Rotablation in the Very Elderly - Safer than We Think?

Vinoda Sharma1, Fairoz Abdul1, Syed Tasneem Haider2

  • 1Birmingham City Hospital, Dudley Road, Birmingham B18 7QH, UK.

Insights

Percutaneous Coronary Intervention (PCI) with rotablation is safe for patients aged 80 and over. Outcomes were similar to younger patients, despite older individuals presenting with acute coronary syndrome (ACS).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Cardiology

Background:

  • Calcified coronary artery stenosis presents a significant challenge for Percutaneous Coronary Intervention (PCI).
  • Rotablation is a key technique for calcium modification during PCI, used in 1-3% of cases.
  • Limited data exists on rotablation outcomes in patients aged 80 years and older, who are perceived to be at higher risk.

Purpose of the Study:

  • To compare the outcomes of PCI with rotablation between patients aged 80 years and older and those younger than 80 years.
  • To evaluate in-hospital outcomes and 30-day mortality risk in these distinct age groups.

Main Methods:

  • A retrospective analysis of consecutive patients undergoing rotablation and PCI across three UK centers from 2014-2017.
  • Comparison of in-hospital composite outcomes (including stroke, myocardial infarction, death, and procedural complications) and 30-day mortality risk scores between the two age groups.
  • Data collected included baseline characteristics, angiographic findings, access site, and clinical outcomes.

Main Results:

  • A total of 213 patients were included, with 71 (33.3%) aged 80 years or older.
  • Older patients were more likely to present with acute coronary syndrome (ACS) (53.5% vs. 33.8%) and had longer hospital stays (2.8 vs. 1.3 days).
  • In-hospital composite outcomes were similar between groups (5.6% vs. 4.9%), with no significant difference (p=1.0). The 30-day mortality risk score was higher in the older group (2.5% vs. <1%).

Conclusions:

  • PCI with rotablation in very elderly patients (≥80 years) yields outcomes comparable to younger patients.
  • Despite a higher incidence of ACS and increased perceived risk, elderly patients undergoing rotablation experience similar in-hospital safety profiles.
  • These findings support the use of rotablation in carefully selected elderly patients with complex coronary artery disease.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
163
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
146
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
116
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
374
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
123